Innovative Approaches to the Treatment of Neovascular Retinal Diseases

The integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patient adherence. However, suboptimal responses to therapy along with loss of patient adherence from treatment burden has defined a need for the development of novel treatments and sustained delivery options for the management of neovascular retinal diseases. Within this 6-part podcast series, experts in the field evaluate the latest safety and efficacy findings pertaining to emerging therapies that may advance the treatment of neovascular diseases, as well as provide discussion on how these emerging therapies may be incorporated into real-world practice.